MétaCan
Menu
Back to cohort
Record W4220994842 · doi:10.1101/2022.03.28.22273040

Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

2022· preprint· en· W4220994842 on OpenAlexafffund
Guillaume Butler‐Laporte, Gundula Povysil, Jack A. Kosmicki, Elizabeth T. Cirulli, Theodore G. Drivas, Simone Furini, Chadi Saad, Axel Schmidt, Pawel Olszewski, Urszula Korotko, Mathieu Quinodoz, Elifnaz Çelik, Kousik Kundu, Klaudia Walter, Junghyung Jung, Amy Stockwell, Laura Sloofman, Daniel M. Jordan, Ryan C. Thompson, Diane M. Del Valle, Nicole W. Simons, Esther Cheng, Robert Sebra, Eric E. Schadt, Seunghee Schulze-Kim, Sacha Gnjatic, Miriam Mérad, Joseph D. Buxbaum, Noam D. Beckmann, Alexander W. Charney, Bartlomiej Przychodzen, Timothy S. Chang, Tess D. Pottinger, Ning Shang, Fabian Brand, Francesca Fava, Francesca Mari, Karolina Chwiałkowska, Magdalena Niemira, Szymon Puła, J. Kenneth Baillie, Alexander Stuckey, Antonio Salas, Xabier Bello, Jacobo Pardo‐Seco, Alberto Gómez‐Carballa, Irene Rivero‐Calle, Federico Martinón‐Torres, Andrea Ganna, Konrad J. Karczewski, Kumar Veerapen, Mathieu Bourgey, Guillaume Bourque, Robert Eveleigh, Vincenzo Forgetta, David Morrison, David Langlais, Mark Lathrop, Vincent Mooser, Tomoko Nakanishi, Robert Frithiof, Michael Hultström, Miklós Lipcsey, Yanara Marincevic-Zuniga, Jessica Nordlund, Kelly M. Schiabor Barrett, William Lee, Alexandre Bolze, Simon White, Stephen Riffle, Francisco Tanudjaja, Efren Sandoval, Iva Neveux, Shaun Dabe, Nicolas Casadei, Susanne Motameny, Manal Alaamery, Salam Massadeh, Nora Aljawini, Mansour Almutairi, Yaseen M. Arabi, Saleh A. Alqahtan, Fawz S. Al Harthi, Amal Almutairi, Fatima Alqubaishi, Sarah Alotaibi, Albandari Binowayn, Ebtehal Alsolm, Hadeel El Bardisy, Mohammad Fawzy, Daniel H. Geschwind, Stephanie A. Arteaga, Alexis Stephens, Manish J. Butte, Paul C. Boutros, Takafumi N. Yamaguchi, Shu Tao, Stefan E. Eng, Timothy Sanders, Paul Tung, Michael E. Broudy, Yu Pan, Alfredo González, Nikhil Chavan, Ruth Johnson, Bogdan Paşaniuc, Brian L. Yaspan, Sandra Smieszek, Carlo Rivolta, Stéphanie Bibert, Pierre–Yves Bochud, M Dabrowski, Paweł Zawadzki, Mateusz Sypniewski, Elżbieta Kaja, Pajaree Chariyavilaskul, Voraphoj Nilaratanakul, Nattiya Hirankarn, Vorasuk Shotelersuk, Monnat Pongpanich, Chureerat Phokaew, Wanna Chetruengchai, K Tokunaga, Masaya Sugiyama, Yosuke Kawai, Takanori Hasegawa, Tatsuhiko Naito, Ho Namkoong, Ryuya Edahiro, Akinori Kimura, Seishi Ogawa, Koichi Fukunaga, Yukinori Okada, Seiya Imoto, Satoru Miyano, Serghei Mangul, Malak Abedalthagafi, Hugo Zeberg, Joseph J. Grzymski, Nicole Washington, Stephan Ossowski, Kerstin U. Ludwig, Eva C. Schulte, Olaf Rieß, Marcin Moniuszko, Mirosław Kwaśniewski, Hamdi Mbarek, Said I. Ismail, Anurag Verma, David B. Goldstein, Krzysztof Kiryluk, Alessandra Renieri, Manuel A. R. Ferreira, J. Brent Richards

Bibliographic record

VenuemedRxiv · 2022
Typepreprint
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsMcGill Genome CentreColumbia CollegeMcGill UniversityJewish General HospitalMcGill University Health Centre
FundersNational Center for Advancing Translational SciencesMedical Research CouncilFonds de Recherche du Québec - SantéCanadian Institutes of Health ResearchPerelman School of Medicine, University of PennsylvaniaNational Institutes of HealthFondation de l'Hôpital général juifAxencia Galega de InnovaciónRheinische Friedrich-Wilhelms-Universität BonnFondation LeenaardsTechnische Universität MünchenKing Abdulaziz City for Science and TechnologyJewish General HospitalKnut och Alice Wallenbergs StiftelseNational Science and Technology Development AgencySchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungAgencja Badań MedycznychMcGill UniversityJapan Agency for Medical Research and DevelopmentDipartimenti di EccellenzaDeutsche ForschungsgemeinschaftUniversity of PennsylvaniaPublic Health AgencyEuropean CommissionMinistero dell’Istruzione, dell’Università e della RicercaBritish Heart FoundationThailand Research FundPublic Health Agency of CanadaBundesministerium für Bildung und ForschungNHS Blood and TransplantNational Institute for Health and Care ResearchCancer Research UKUniversity of Pennsylvania Health SystemUniversità degli Studi di SienaScience for Life LaboratoryNational Science FoundationCompute CanadaDr. Rolf M. Schwiete StiftungNational Center for Global Health and MedicineJapan Science and Technology AgencyVetenskapsrådetGeorgia Clinical and Translational Science AllianceChulalongkorn UniversityHealth Systems Research InstituteQatar Foundation
KeywordsExome sequencingExomeGenome-wide association studyDiseaseGeneticsBiologyGenetic associationPopulationGenotypeMedicineSingle-nucleotide polymorphismGeneMutationPathology

Abstract

fetched live from OpenAlex

Abstract Host genetics is a key determinant of COVID-19 outcomes. Previously, the COVID-19 Host Genetics Initiative genome-wide association study used common variants to identify multiple loci associated with COVID-19 outcomes. However, variants with the largest impact on COVID-19 outcomes are expected to be rare in the population. Hence, studying rare variants may provide additional insights into disease susceptibility and pathogenesis, thereby informing therapeutics development. Here, we combined whole-exome and whole-genome sequencing from 21 cohorts across 12 countries and performed rare variant exome-wide burden analyses for COVID-19 outcomes. In an analysis of 5,085 severe disease cases and 571,737 controls, we observed that carrying a rare deleterious variant in the SARS-CoV-2 sensor toll-like receptor TLR7 (on chromosome X) was associated with a 5.3-fold increase in severe disease (95% CI: 2.75-10.05, p=5.41×10 −7 ). This association was consistent across sexes. These results further support TLR7 as a genetic determinant of severe disease and suggest that larger studies on rare variants influencing COVID-19 outcomes could provide additional insights. Author Summary COVID-19 clinical outcomes vary immensely, but a patient’s genetic make-up is an important determinant of how they will fare against the virus. While many genetic variants commonly found in the populations were previously found to be contributing to more severe disease by the COVID-19 Host Genetics Initiative, it isn’t clear if more rare variants found in less individuals could also play a role. This is important because genetic variants with the largest impact on COVID-19 severity are expected to be rarely found in the population, and these rare variants require different technologies to be studies (usually whole-exome or whole-genome sequencing). Here, we combined sequencing results from 21 cohorts across 12 countries to perform a rare variant association study. In an analysis comprising 5,085 participants with severe COVID-19 and 571,737 controls, we found that the gene for toll-like receptor 7 ( TLR7 ) on chromosome X was an important determinant of severe COVID-19. Importantly, despite being found on a sex chromosome, this observation was consistent across both sexes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.008
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score0.017

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.008
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0010.002
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.117
GPT teacher head0.418
Teacher spread0.301 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations7
Published2022
Admission routes2
Has abstractyes

Explore more

Same venuemedRxivSame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207